Follow the Pharmanutra Pharmanutra S.p.a.: First Significant Sales Results in China stock price and the full management transaction log of the company, a listed equity based in Italy. Shares trade on IT IT, under the authority of Consob. Operating in the Health Care sector, Pharmanutra Pharmanutra S.p.a.: First Significant Sales Results in China has logged 1 public disclosures. Market capitalisation: €861.8m. The latest transaction was reported on 18 November 2024 (Other). Among the most active insiders: Unknown. The full history is openly available.
Analysts rate Pharmanutra Pharmanutra S.p.a.: First Significant Sales Results in China Strong Buy (bullish), based on 3 analysts. Average price target: €81.33.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.